News-Medical.Net on MSN
Enzyme helps maintain retinal progenitor cells during eye development
The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain. During development, all the specialized neurons in the ...
4don MSN
Cloaked stem cells evade immune rejection in mice, pointing to a potential universal donor cell line
A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...
A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.
A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.
Hematopoietic stem cells (HSCs) are the cornerstone of lifelong blood formation, arising during embryogenesis from specialised endothelial precursors in a process known as the ...
A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...
Researchers have created a way to guide and control the development of stem cells into specific tissues and organs, opening the door to developing a means of one day tackling complex diseases like ...
A study in mice has found that maternal gut microbiome composition during pregnancy has long-term effects on offspring stem cell growth and development. The researchers, headed by Parag Kundu, PhD, at ...
Hosted on MSN
RNA modifications control how stem cells develop into retinal cells, research demonstrates
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message (mRNA), which is then converted into a protein. Although DNA remains the same ...
The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...
Morning Overview on MSN
Japan approves stem-cell therapies for Parkinson’s and severe heart failure
Japan’s health ministry has granted conditional, time-limited authorization for two stem-cell therapies derived from induced pluripotent stem (iPS) cells, endorsing them for use based on early safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results